Qing Duan

Title: The Innovative Contributions of Inventor Qing Duan

Introduction: Qing Duan, an accomplished inventor based in Shanghai, China, has made significant strides in the field of biomedicine. With an impressive portfolio comprising seven patents, his contributions are influential in the development of novel therapeutic antibodies targeting critical cancer-related proteins.

Latest Patents: Among his most recent innovations is the patent for the SEMA4D antibody, which includes its preparation method and therapeutic applications. This monoclonal antibody is designed to bind specifically to the SEMA4D antigen, displaying remarkable anti-tumor activities. Another noteworthy patent is his work on the Anti-human LAG-3 monoclonal antibody. This invention features a novel antibody targeting the LAG-3 protein, characterized by high specificity and affinity. The associated preparation method emphasizes the antibody's potential in anti-tumor therapy.

Career Highlights: Qing Duan has a rich professional background, having worked with respected organizations such as Jiangsu Huaiyu Pharmaceutical Co., Ltd. and Shanghai Pharmaexplorer Co., Ltd. His experience in these leading pharmaceutical companies has equipped him with the skills and knowledge to advance his innovative projects.

Collaborations: Throughout his career, Qing has collaborated with talented individuals in the field, including Lile Liu and Tatchi Teddy Yang. These partnerships have contributed to the successful development of his groundbreaking inventions and further enhanced the impact of his work in the industry.

Conclusion: In summary, Qing Duan exemplifies the spirit of innovation with his substantial contributions to antibody development and cancer research. His patents reflect a commitment to advancing medical therapies and improving patient outcomes, making him a prominent figure in the field of biomedical inventions.